Article
A Randomized Controlled Trial of Propranolol for Infantile Hemangiomas
Marcia Hogeling, Susan Adams and Orli Wargon
Pediatrics August 2011, 128 (2) e259-e266; DOI: https://doi.org/10.1542/peds.2010-0029
Marcia Hogeling
Susan Adams

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
A Randomized Controlled Trial of Propranolol for Infantile Hemangiomas
Marcia Hogeling, Susan Adams, Orli Wargon
Pediatrics Aug 2011, 128 (2) e259-e266; DOI: 10.1542/peds.2010-0029
Jump to section
Related Articles
- No related articles found.
Cited By...
- A Newborn with a Facial Lesion
- Safety of Oral Propranolol for the Treatment of Infantile Hemangioma: A Systematic Review
- Pharmacologic Interventions for Infantile Hemangioma: A Meta-analysis
- Diagnosis and Management of Infantile Hemangioma
- Incidence and treatment of infantile haemangioma in preterm infants
- Update on Propranolol for Infantile Hemangioma: Where Are We Now?
- Novel treatment for infantile hemangiomas
- Propranolol for infantile haemangiomas: review of report of a consensus conference
- RCT of Timolol Maleate Gel for Superficial Infantile Hemangiomas in 5- to 24-Week-Olds
- Pediatric Neck Masses
- Infantile Hemangiomas: An Update on Pathogenesis and Therapy
- Hemangiomas Treated with Propranolol: Do the Rewards Outweigh the Risks?
- Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference
- Preterm Infant With a Flat, Erythematous Patch
- Propranolol reduced volume, colour and elevation of infantile haemangiomas
- Management of difficult infantile haemangiomas
- Oral Propranolol for Infantile Hemangioma: The New Treatment of Choice?